Name: Amy Acton, the "Dr. Fauci of Ohio," considered for Senate seat
Brand: axios.com
SKU: axios-com-82
Availability: OnlineOnly

critic

Amy Acton, the "Dr. Fauci of Ohio," considered for Senate seat

preview

Amy Acton. Photo: Public DomainSome Democrats are looking to a political outsider described as the "Dr. Fauci of Ohio" to replace Rob Portman in the U.S. Senate. Why it matters: Amy Acton, former director of the Ohio Department of Health, gained a grassroots following last year when she briefed Ohioans about the state of the coronavirus. Her celebrity could help in a Republican state, and against potential GOP rivals such as Rep. Jim Jordan.Driving the news: Portman, a Republican, Monday he will not run for a third term in 2022, citing "partisan gridlock."Background: Historically, open seats are more competitive, and both parties' primaries are expected to be crowded.What they're saying: "Sometimes I feel I don't deserve all this attention I'm getting," Acton last March.Ohio is a challenging state for Democrats. Donald Trump won the state by about 8 points in both the 2016 and 2020 elections.Sen. Rob Portman (R-Ohio) announced Monday he will not run for a third term in the U.S. Senate in 2022, citing "partisan gridlock."Why it matters: It's a surprise retirement from a prominent Senate Republican who easily won re-election in 2016 and was expected to do so again in 2022, creating an open Senate seat in a red-leaning swing state.President Biden will sign new executive actions today that provide the clearest signs yet of his climate plans — elevating the issue to a national security priority and kicking off an intense battle with the oil industry.Driving the news: One move will freeze issuance of new oil-and-gas leases on public lands and waters "to the extent possible," per a White House summary.Silicon Valley may be a "state of mind," but it's also very much a real enclave in Northern California. Now, a growing faction of the tech industry is boycotting it. Why it matters: The Bay Area is facing for the first time the prospect of losing its crown as the top destination for tech workers and startups — which could have an economic impact on the region and force it to reckon with its local issues.

Amy Acton. Photo: Public DomainSome Democrats are looking to a political outsider described as the "Dr. Fauci of Ohio" to replace Rob Portman in the U.S. Senate. Why it matters: Amy Acton, former director of the Ohio Department of Health, gained a grassroots following last year when she briefed Ohioans about the state of the coronavirus. Her celebrity could help in a Republican state, and against potential GOP rivals such as Rep. Jim Jordan.Driving the news: Portman, a Republican, Monday he will not run for a third term in 2022, citing "partisan gridlock."Background: Historically, open...

public

Alexi is a political reporter at Axios. She covers the 2020 presidential election, focusing on the cultural concerns and trends that will help decide the next president.

https://www.axios.com/authors/Alexi_McCammond

Alexi McCammond

Smart Brevity worthy of people's time, attention and trust. Subscribe to our newsletters: https://bit.ly/3hMCmVn

axios.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Amy Acton, the "Dr. Fauci of Ohio," considered for Senate seat

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS